Eton Pharmaceuticals Stock Price on December 14, 2024

ETON Stock  USD 12.35  0.19  1.56%   
Below is the normalized historical share price chart for Eton Pharmaceuticals extending back to November 13, 2018. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Eton Pharmaceuticals stands at 12.35, as last reported on the 16th of December 2024, with the highest price reaching 12.59 and the lowest price hitting 12.15 during the day.
IPO Date
13th of November 2018
200 Day MA
4.5932
50 Day MA
6.9582
Beta
1.257
 
Covid
If you're considering investing in Eton Stock, it is important to understand the factors that can impact its price. Eton Pharmaceuticals is somewhat reliable given 3 months investment horizon. Eton Pharmaceuticals secures Sharpe Ratio (or Efficiency) of 0.3, which denotes the company had a 0.3% return per unit of risk over the last 3 months. We were able to break down and interpolate data for twenty-nine different technical indicators, which can help you to evaluate if expected returns of 1.3% are justified by taking the suggested risk. Use Eton Pharmaceuticals Coefficient Of Variation of 284.33, mean deviation of 3.0, and Downside Deviation of 3.78 to evaluate company specific risk that cannot be diversified away.
  
As of the 16th of December 2024, Total Stockholder Equity is likely to drop to about 12.7 M. In addition to that, Common Stock Total Equity is likely to drop to about 20 K. At this time, Eton Pharmaceuticals' Price Fair Value is very stable compared to the past year. Eton Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.3024

Best PortfolioBest Equity
Good Returns
Average Returns
Small ReturnsETON
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 4.29
  actual daily
38
62% of assets are more volatile

Expected Return

 1.3
  actual daily
25
75% of assets have higher returns

Risk-Adjusted Return

 0.3
  actual daily
23
77% of assets perform better
Based on monthly moving average Eton Pharmaceuticals is performing at about 23% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Eton Pharmaceuticals by adding it to a well-diversified portfolio.
Price Book
19.966
Enterprise Value Ebitda
51.2617
Price Sales
10.1678
Shares Float
21.7 M
Wall Street Target Price
13

Eton Pharmaceuticals Main Headline on 13th of December 2024

Filed transaction by Eton Pharmaceuticals Officer Chief Business Officer. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3

Eton Pharmaceuticals Valuation on December 14, 2024

It is possible to determine the worth of Eton Pharmaceuticals on a given historical date. On December 14, 2024 Eton was worth 12.18 at the beginning of the trading date compared to the closed value of 12.35. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Eton Pharmaceuticals stock. Still, in general, we apply an absolute valuation method to find Eton Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Eton Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Eton Pharmaceuticals' related companies.
 Open High Low Close Volume
  12.10    12.56    12.00    12.16    158,218  
12/13/2024
  12.18    12.59    12.15    12.35    117,055  
  12.18    12.59    12.15    12.35    0.00  
Backtest Eton Pharmaceuticals  |  Eton Pharmaceuticals History  |  Eton Pharmaceuticals Valuation   PreviousNext  
Open Value
12.18
12.35
Closing Value
25.05
Upside

Eton Pharmaceuticals Trading Date Momentum on December 14, 2024

On December 16 2024 Eton Pharmaceuticals was traded for  12.35  at the closing time. The top price for the day was 12.59  and the lowest listed price was  12.15 . There was no trading activity during the period 0.0. Lack of trading volume on December 16, 2024 did not affect price variability. The overall trading delta against the current closing price is 1.38% .

Eton Pharmaceuticals Fundamentals Correlations and Trends

By evaluating Eton Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Eton Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Eton financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Eton Pharmaceuticals Stock history

Eton Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Eton is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Eton Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Eton Pharmaceuticals stock prices may prove useful in developing a viable investing in Eton Pharmaceuticals
Last ReportedProjected for Next Year
Common Stock Shares Outstanding25.6 M21.6 M
Net Loss-10.4 M-10.9 M

Eton Pharmaceuticals Quarterly Net Working Capital

10.02 Million

Eton Pharmaceuticals Stock Technical Analysis

Eton Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Eton Pharmaceuticals technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Eton Pharmaceuticals trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Eton Pharmaceuticals Period Price Range

Low
December 16, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

Eton Pharmaceuticals cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Eton Pharmaceuticals December 16, 2024 Market Strength

Market strength indicators help investors to evaluate how Eton Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Eton Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Eton Pharmaceuticals stock market strength indicators, traders can identify Eton Pharmaceuticals entry and exit signals to maximize returns

Eton Pharmaceuticals Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Eton Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Eton Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Eton to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
When determining whether Eton Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Eton Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Eton Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Eton Pharmaceuticals Stock:
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Eton Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
To learn how to invest in Eton Stock, please use our How to Invest in Eton Pharmaceuticals guide.
You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Eton Pharmaceuticals. If investors know Eton will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Eton Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.13)
Earnings Share
(0.26)
Revenue Per Share
1.219
Quarterly Revenue Growth
(0.24)
Return On Assets
(0.12)
The market value of Eton Pharmaceuticals is measured differently than its book value, which is the value of Eton that is recorded on the company's balance sheet. Investors also form their own opinion of Eton Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Eton Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Eton Pharmaceuticals' market value can be influenced by many factors that don't directly affect Eton Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Eton Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Eton Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Eton Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.